Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2000 Nov;55(11):934–939. doi: 10.1136/thorax.55.11.934

Pulmonary arterial hypertension in patients with sleep apnoea syndrome

E Bady 1, A Achkar 1, S Pascal 1, E Orvoen-Frija 1, J Laaban 1
PMCID: PMC1745626  PMID: 11050263

Abstract

BACKGROUND—Pulmonary arterial hypertension (PAH) in patients with sleep apnoea syndrome (SAS) is classically ascribed to associated chronic obstructive pulmonary disease (COPD). The aim of this retrospective study was to evaluate the possible occurrence of PAH as a complication of SAS in patients without COPD.
METHODS—Right heart catheterisation was performed in 44 patients with SAS and without COPD confirmed by polysomnography (apnoea index >5/h) admitted for the administration of nasal continuous positive airway pressure (CPAP).
RESULTS—Precapillary PAH, defined as mean pulmonary arterial pressure of >20 mm Hg with pulmonary capillary wedge pressure <15 mm Hg, was observed in 12/44 (27%) patients with SAS. There were no significant differences in apnoea index between patients with (PAH+) and those without PAH (PAH-) (42.6 (26.3) versus 35.8 (21.7) apnoeas/h). The PAH+ group differed significantly from the PAH- group in the following respects: lower daytime arterial oxygen tension (PaO2) (9.6 (1.1) versus 11.3 (1.5) kPa, p=0.0006); higher daytime arterial carbon dioxide tension (PaCO2) (5.8 (0.5) versus 5.3 (0.5) kPa, p=0.002); more severe nocturnal hypoxaemia with a higher percentage of total sleep time spent at SaO2 <80% (32.2(28.5)% versus 10.7 (18.8)%, p=0.005); and higher body mass index (BMI) (37.4 (6) versus 30.3 (6.7) kg/m2, p=0.002). The PAH+ patients had significantly lower values of vital capacity (VC) (87 (14)% predicted versus 105 (20)% predicted, p=0.005), forced expiratory volume in one second (FEV1) (82 (14)% predicted versus 101 (17)% predicted, p=0.001), expiratory reserve volume (40 (16)% predicted versus 77 (41)% predicted, p=0.003), and total lung capacity (87 (13)% predicted versus 98 (18)% predicted, p=0.04). Stepwise multiple regression analysis showed that mean pulmonary artery pressure (PAPm) was positively correlated with BMI and negatively with PaO2.
CONCLUSION—Pulmonary arterial hypertension is frequently observed in patients with SAS, even when COPD is absent, and appears to be related to the severity of obesity and its respiratory mechanical consequences.



Full Text

The Full Text of this article is available as a PDF (154.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmed Q., Chung-Park M., Tomashefski J. F., Jr Cardiopulmonary pathology in patients with sleep apnea/obesity hypoventilation syndrome. Hum Pathol. 1997 Mar;28(3):264–269. doi: 10.1016/s0046-8177(97)90122-2. [DOI] [PubMed] [Google Scholar]
  2. Bonsignore M. R., Marrone O., Insalaco G., Bonsignore G. The cardiovascular effects of obstructive sleep apnoeas: analysis of pathogenic mechanisms. Eur Respir J. 1994 Apr;7(4):786–805. doi: 10.1183/09031936.94.07040786. [DOI] [PubMed] [Google Scholar]
  3. Bradley T. D. Right and left ventricular functional impairment and sleep apnea. Clin Chest Med. 1992 Sep;13(3):459–479. [PubMed] [Google Scholar]
  4. Bradley T. D., Rutherford R., Grossman R. F., Lue F., Zamel N., Moldofsky H., Phillipson E. A. Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome. Am Rev Respir Dis. 1985 Jun;131(6):835–839. doi: 10.1164/arrd.1985.131.6.835. [DOI] [PubMed] [Google Scholar]
  5. Chaouat A., Weitzenblum E., Krieger J., Oswald M., Kessler R. Pulmonary hemodynamics in the obstructive sleep apnea syndrome. Results in 220 consecutive patients. Chest. 1996 Feb;109(2):380–386. doi: 10.1378/chest.109.2.380. [DOI] [PubMed] [Google Scholar]
  6. Coccagna G., Mantovani M., Brignani F., Parchi C., Lugaresi E. Continuous recording of the pulmonary and systemic arterial pressure during sleep in syndromes of hypersomnia with periodic breathing. Bull Physiopathol Respir (Nancy) 1972 Sep-Oct;8(5):1159–1172. [PubMed] [Google Scholar]
  7. Fletcher E. C., Schaaf J. W., Miller J., Fletcher J. G. Long-term cardiopulmonary sequelae in patients with sleep apnea and chronic lung disease. Am Rev Respir Dis. 1987 Mar;135(3):525–533. doi: 10.1164/arrd.1987.135.3.525. [DOI] [PubMed] [Google Scholar]
  8. Kay J. M., Suyama K. L., Keane P. M. Effect of intermittent normoxia on muscularization of pulmonary arterioles induced by chronic hypoxia in rats. Am Rev Respir Dis. 1981 Apr;123(4 Pt 1):454–458. doi: 10.1164/arrd.1981.123.4.454. [DOI] [PubMed] [Google Scholar]
  9. Kessler R., Chaouat A., Weitzenblum E., Oswald M., Ehrhart M., Apprill M., Krieger J. Pulmonary hypertension in the obstructive sleep apnoea syndrome: prevalence, causes and therapeutic consequences. Eur Respir J. 1996 Apr;9(4):787–794. doi: 10.1183/09031936.96.09040787. [DOI] [PubMed] [Google Scholar]
  10. Krieger B. P., de la Hoz R. E. Altitude-related pulmonary disorders. Crit Care Clin. 1999 Apr;15(2):265-80, viii. doi: 10.1016/s0749-0704(05)70054-3. [DOI] [PubMed] [Google Scholar]
  11. Krieger J., Sforza E., Apprill M., Lampert E., Weitzenblum E., Ratomaharo J. Pulmonary hypertension, hypoxemia, and hypercapnia in obstructive sleep apnea patients. Chest. 1989 Oct;96(4):729–737. doi: 10.1378/chest.96.4.729. [DOI] [PubMed] [Google Scholar]
  12. Laks L., Lehrhaft B., Grunstein R. R., Sullivan C. E. Pulmonary artery pressure response to hypoxia in sleep apnea. Am J Respir Crit Care Med. 1997 Jan;155(1):193–198. doi: 10.1164/ajrccm.155.1.9001311. [DOI] [PubMed] [Google Scholar]
  13. Laks L., Lehrhaft B., Grunstein R. R., Sullivan C. E. Pulmonary hypertension in obstructive sleep apnoea. Eur Respir J. 1995 Apr;8(4):537–541. [PubMed] [Google Scholar]
  14. Ray C. S., Sue D. Y., Bray G., Hansen J. E., Wasserman K. Effects of obesity on respiratory function. Am Rev Respir Dis. 1983 Sep;128(3):501–506. doi: 10.1164/arrd.1983.128.3.501. [DOI] [PubMed] [Google Scholar]
  15. Sajkov D., Cowie R. J., Thornton A. T., Espinoza H. A., McEvoy R. D. Pulmonary hypertension and hypoxemia in obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 1994 Feb;149(2 Pt 1):416–422. doi: 10.1164/ajrccm.149.2.8306039. [DOI] [PubMed] [Google Scholar]
  16. Sajkov D., Wang T., Saunders N. A., Bune A. J., Neill A. M., Douglas Mcevoy R. Daytime pulmonary hemodynamics in patients with obstructive sleep apnea without lung disease. Am J Respir Crit Care Med. 1999 May;159(5 Pt 1):1518–1526. doi: 10.1164/ajrccm.159.5.9805086. [DOI] [PubMed] [Google Scholar]
  17. Sanner B. M., Doberauer C., Konermann M., Sturm A., Zidek W. Pulmonary hypertension in patients with obstructive sleep apnea syndrome. Arch Intern Med. 1997 Nov 24;157(21):2483–2487. [PubMed] [Google Scholar]
  18. Standardized lung function testing. Report working party. Bull Eur Physiopathol Respir. 1983 Jul;19 (Suppl 5):1–95. [PubMed] [Google Scholar]
  19. Sériès F., Cormier Y., La Forge J. Role of lung volumes in sleep apnoea-related oxygen desaturation. Eur Respir J. 1989 Jan;2(1):26–30. [PubMed] [Google Scholar]
  20. Tilkian A. G., Guilleminault C., Schroeder J. S., Lehrman K. L., Simmons F. B., Dement W. C. Hemodynamics in sleep-induced apnea. Studies during wakefulness and sleep. Ann Intern Med. 1976 Dec;85(6):714–719. doi: 10.7326/0003-4819-85-6-714. [DOI] [PubMed] [Google Scholar]
  21. Weitzenblum E., Krieger J., Apprill M., Vallée E., Ehrhart M., Ratomaharo J., Oswald M., Kurtz D. Daytime pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis. 1988 Aug;138(2):345–349. doi: 10.1164/ajrccm/138.2.345. [DOI] [PubMed] [Google Scholar]
  22. Weitzenblum E., Schrijen F., Mohan-Kumar T., Colas des Francs V., Lockhart A. Variability of the pulmonary vascular response to acute hypoxia in chronic bronchitis. Chest. 1988 Oct;94(4):772–778. doi: 10.1378/chest.94.4.772. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES